Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Seto

Showing results (121-130 of 242) with videos related to

Pageof 25
Sort By:
The Oncologist|July 13, 2020
Erlotinib for Non-Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101)Kaname Nosaki, Takeharu Yamanaka, Akinobu Hamada, et al.
Thoracic Cancer|May 18, 2021
Sarcoid-like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumabShinkichi Takamori, Nobuki Furubayashi, Kenichi Taguchi, et al.
Critical Reviews in Oncology/Hematology|March 16, 2023
Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implicationsGouji Toyokawa, Francesca Bersani, Paolo Bironzo, et al.
Internal Medicine (Tokyo, Japan)|March 16, 2010
Incidentally proven pulmonary "ALKoma"Atsushi Osoegawa, Kaname Nosaki, Hitoshi Miyamoto, et al.
Cancer Science|July 12, 2023
Brigatinib in Japanese patients with ALK-positive non-small-cell lung cancer: Final results of the phase 2 J-ALTA trialTatsuya Yoshida, Toru Kumagai, Ryo Toyozawa, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2019
Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER studyYuki Katsuya, Hidehito Horinouchi, Takashi Seto, et al.
Japanese Journal of Clinical Oncology|August 7, 2013
Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinomaFumihiko Hirai, Takashi Seto, Takeharu Yamanaka, et al.
International Journal of Clinical Oncology|October 26, 2013
Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapyGouji Toyokawa, Mitsuhiro Takenoyama, Fumihiko Hirai, et al.
Cancer Science|May 20, 2014
Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology GroupHaruyasu Murakami, Takeharu Yamanaka, Takashi Seto, et al.
Annals of Surgical Oncology|July 18, 2020
Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung CancerShinkichi Takamori, Mototsugu Shimokawa, Taichi Matsubara, et al.
Pageof 25

Showing results (121-130 of 242) with videos related to

Sort By:
Pageof 25
The Oncologist|July 13, 2020
Erlotinib for Non-Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101)Kaname Nosaki, Takeharu Yamanaka, Akinobu Hamada, et al.
Thoracic Cancer|May 18, 2021
Sarcoid-like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumabShinkichi Takamori, Nobuki Furubayashi, Kenichi Taguchi, et al.
Critical Reviews in Oncology/Hematology|March 16, 2023
Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implicationsGouji Toyokawa, Francesca Bersani, Paolo Bironzo, et al.
Internal Medicine (Tokyo, Japan)|March 16, 2010
Incidentally proven pulmonary "ALKoma"Atsushi Osoegawa, Kaname Nosaki, Hitoshi Miyamoto, et al.
Cancer Science|July 12, 2023
Brigatinib in Japanese patients with ALK-positive non-small-cell lung cancer: Final results of the phase 2 J-ALTA trialTatsuya Yoshida, Toru Kumagai, Ryo Toyozawa, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2019
Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER studyYuki Katsuya, Hidehito Horinouchi, Takashi Seto, et al.
Japanese Journal of Clinical Oncology|August 7, 2013
Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinomaFumihiko Hirai, Takashi Seto, Takeharu Yamanaka, et al.
International Journal of Clinical Oncology|October 26, 2013
Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapyGouji Toyokawa, Mitsuhiro Takenoyama, Fumihiko Hirai, et al.
Cancer Science|May 20, 2014
Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology GroupHaruyasu Murakami, Takeharu Yamanaka, Takashi Seto, et al.
Annals of Surgical Oncology|July 18, 2020
Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung CancerShinkichi Takamori, Mototsugu Shimokawa, Taichi Matsubara, et al.
Pageof 25